Annovis Bio Inc. (ANVS)
NYSE: ANVS
· Real-Time Price · USD
1.82
0.14 (8.33%)
At close: Oct 15, 2025, 3:59 PM
1.84
1.10%
After-hours: Oct 15, 2025, 07:33 PM EDT
8.33% (1D)
| Bid | 1.75 |
| Market Cap | 35.46M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -30.26M |
| EPS (ttm) | -2.1 |
| PE Ratio (ttm) | -0.87 |
| Forward PE | -1.34 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 1.85 |
| Volume | 843,349 |
| Avg. Volume (20D) | 518,860 |
| Open | 1.62 |
| Previous Close | 1.68 |
| Day's Range | 1.62 - 1.85 |
| 52-Week Range | 1.11 - 10.54 |
| Beta | 1.63 |
| Ex-Dividend Date | n/a |
About ANVS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ANVS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ANVS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts5 days ago
-22.73%
Annovis Bio shares are trading lower after the com...
Unlock content with
Pro Subscription
6 days ago
-3.08%
ANVS stock has given up its prior gain. Annovis Bio shares were trading higher after the company announced the analysis of patient samples from the Phase 2/3 AD study.
